Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H23NO2 |
Molecular Weight | 273.37 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2
InChI
InChIKey=WDEFBBTXULIOBB-WBVHZDCISA-N
InChI=1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3/t15-,17+/m1/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The opiate-like action of tilidine is mediated by metabolites. | 1978 Sep |
|
Antagonism between tilidine and naloxone on cerebral potentials and pain ratings in man. | 1983 Mar 4 |
|
[Erroneous intravenous injection of adrenaline]. | 1998 May 29 |
|
Actions of tilidine and nortilidine on cloned opioid receptors. | 2005 Jan 4 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15627429
The selectivity of tilidine and nortilidine for human opioid and opioid-like receptors stably expressed in CHO-K1 cells, using the inhibition of the forskolin (FK)-induced accumulation of cAMP as the endpoint was measured. In cells expressing the Mu opioid receptor, tilidine and nortilidine inhibited cAMP accumulation with IC50 of 11 microM and 110 nM, respectively.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
||
|
WHO-VATC |
QN02AX01
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
||
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
||
|
DEA NO. |
9750
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
||
|
WHO-ATC |
N02AX01
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2663
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
DB13787
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
D013993
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
243-774-7
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
ALTERNATIVE | |||
|
10597
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | RxNorm | ||
|
GY33N31E9Y
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
M10864
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | Merck Index | ||
|
257-522-9
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
TILIDINE
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
20380-58-9
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
SUPERSEDED | |||
|
51931-66-9
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
C152628
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
SUB11051MIG
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
2510
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
77823
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY | |||
|
CHEMBL2220384
Created by
admin on Fri Dec 16 15:51:24 UTC 2022 , Edited by admin on Fri Dec 16 15:51:24 UTC 2022
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PRODRUG)
METABOLITE ACTIVE (PRODRUG)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)